Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atrasentan and Zometa for Men With Androgen Independent Prostate Cancer Metastatic to Bone: A Randomized Pilot Study

NCT00181558 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00181558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00181558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atrasentan and Zometa for Men With Androgen Independent Prostate Cancer Metastatic to Bone: A Randomized Pilot Study
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2001
Completion date
December 31, 2006
Enrollment
44
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate, prostate cancer